DoM Faculty Appointments and Promotions – April 2025
Congratulations to the following Chobanian & Avedisian School of Medicine faculty on their recent appointment or promotion.
Clinical Associate Professor
Marcin Trojanowski, MD, Medicine/Rheumatology, specializes in the treatment of systemic sclerosis. He directs the Scleroderma Program, overseeing scleroderma clinical trials, a biorepository and a clinical research database. He oversees the Scleroderma Clinic at Boston Medical Center, which is New England’s largest scleroderma program. Dr. Trojanowski is also recognized as an expert in macrophage activation syndrome, a rare but potentially fatal complication of inflammatory autoimmune rheumatic diseases.
Research Associate Professor
Britta Lassmann, MD, Medicine/Infectious Diseases, is an infectious diseases physician and healthcare technology innovator with expertise in building applications at the intersection of clinical care, public health, analytics and technology. Her research also integrates advanced analytical methods and artificial intelligence (AI) to optimize disease surveillance and outbreak response. She is a co-founder of BEACON, the Biothreats, Emergence, Analysis and Communications Network, a first-of-its-kind, open-source global surveillance platform built to detect emerging infectious diseases in near real time, worldwide. The platform merges the power of AI with a global network of human subject matter experts to provide fast, verified alerts to potential outbreaks. BEACON is housed at BU’s Center on Emerging Infectious Diseases.